154 related articles for article (PubMed ID: 35137110)
1. Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data.
Llewelyn MJ; Grozeva D; Howard P; Euden J; Gerver SM; Hope R; Heginbothom M; Powell N; Richman C; Shaw D; Thomas-Jones E; West RM; Carrol ED; Pallmann P; Sandoe JAT
J Antimicrob Chemother; 2022 Mar; 77(4):1189-1196. PubMed ID: 35137110
[TBL] [Abstract][Full Text] [Related]
2. Comment on: Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data.
Su MC; Park JY; Hsu WT; Huang CY; Hsu CC; Yo CH; Lee CC
J Antimicrob Chemother; 2022 Sep; 77(10):2894-2895. PubMed ID: 35670631
[No Abstract] [Full Text] [Related]
3. Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data-authors' response.
Llewelyn MJ; West RM; Carrol ED; Pallmann P; Sandoe JAT
J Antimicrob Chemother; 2022 Oct; 77(11):3211-3212. PubMed ID: 36124922
[No Abstract] [Full Text] [Related]
4. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
Henley J; Brookes-Howell L; Euden J; Pallmann P; Llewelyn M; Howard P; Powell N; Dark P; Szakmany T; Hellyer TP; Albur M; Hamilton R; Prestwich G; Ogden M; Maboshe W; Sandoe J; Thomas-Jones E; Carrol E; ;
BMJ Open; 2023 Dec; 13(12):e077117. PubMed ID: 38114276
[TBL] [Abstract][Full Text] [Related]
5. Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational Study.
Powell N; Howard P; Llewelyn MJ; Szakmany T; Albur M; Bond SE; Euden J; Brookes-Howell L; Dark P; Hellyer TP; Hopkins S; McCullagh IJ; Ogden M; Pallmann P; Parsons H; Partridge DG; Shaw DE; Shinkins B; Todd S; Thomas-Jones E; West R; Carrol ED; Sandoe JAT
Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34062898
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic dispensing during the COVID-19 pandemic: analysis of Welsh primary care dispensing data.
Wasag DR; Cannings-John R; Hughes K; Ahmed H
Fam Pract; 2022 May; 39(3):420-425. PubMed ID: 34755180
[TBL] [Abstract][Full Text] [Related]
7. Hospital antibiotic consumption-an interrupted time series analysis of the early and late phases of the COVID-19 pandemic in Poland, a retrospective study.
Siewierska M; Gajda M; Opalska A; Brudło M; Krzyściak P; Gryglewska B; Różańska A; Wójkowska-Mach J
Pharmacol Rep; 2023 Jun; 75(3):715-725. PubMed ID: 37017868
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
[TBL] [Abstract][Full Text] [Related]
9. Use of procalcitonin for antibiotic stewardship in patients with COVID-19: A quality improvement project in a district general hospital.
Peters C; Williams K; Un EA; Little L; Saad A; Lendrum K; Thompson N; Weatherley ND; Pegden A
Clin Med (Lond); 2021 Jan; 21(1):e71-e76. PubMed ID: 33355197
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial.
Llewelyn MJ; Budgell EP; Laskawiec-Szkonter M; Cross ELA; Alexander R; Bond S; Coles P; Conlon-Bingham G; Dymond S; Evans M; Fok R; Frost KJ; Garcia-Arias V; Glass S; Gormley C; Gray K; Hamson C; Harvey D; Hills T; Iyer S; Johnson A; Jones N; Kang P; Kiapi G; Mack D; Makanga C; Mawer D; McCullagh B; Mirfenderesky M; McEwen R; Nag S; Nagar A; Northfield J; O'Driscoll J; Pegden A; Porter R; Powell N; Price D; Sheridan E; Slatter M; Stewart B; Watson C; Weichert I; Sivyer K; Wordsworth S; Quaddy J; Santillo M; Krusche A; Roope LSJ; Mowbray F; Hand KS; Dobson M; Crook DW; Vaughan L; Hopkins S; Yardley L; Peto TEA; Walker AS
Lancet Infect Dis; 2023 Feb; 23(2):207-221. PubMed ID: 36206793
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin Evaluation of Antibiotic Use in COVID-19 Hospitalised Patients (PEACH): Protocol for a Retrospective Observational Study.
Euden J; Pallmann P; Grozeva D; Albur M; Bond SE; Brookes-Howell L; Dark P; Hellyer T; Hopkins S; Howard P; Llewelyn MJ; Maboshe W; McCullagh IJ; Ogden M; Parsons H; Partridge D; Powell N; Shaw D; Shinkins B; Szakmany T; Todd S; Thomas-Jones E; West RM; Carrol ED; Sandoe JAT;
Methods Protoc; 2022 Nov; 5(6):. PubMed ID: 36548137
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study.
Webb EJD; Howdon D; Bestwick R; King N; Sandoe JAT; Euden J; Grozeva D; West R; Howard P; Powell N; Albur M; Bond S; Brookes-Howell L; Dark P; Hellyer T; Llewelyn M; McCullagh IJ; Ogden M; Pallmann P; Parsons H; Partridge D; Shaw D; Szakmany T; Todd S; Thomas-Jones E; Carrol ED; Shinkins B;
J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38842487
[TBL] [Abstract][Full Text] [Related]
17. Bacterial infections in patients with COVID-19: the impact of procalcitonin testing on antibiotics prescription in the real world.
Lui GC; Cheung CS; Yip TC; Lai MS; Li TC; Wong GL
BMC Infect Dis; 2024 Jan; 24(1):106. PubMed ID: 38243171
[TBL] [Abstract][Full Text] [Related]
18. The impact of the COVID-19 pandemic on antimicrobial prescribing at a specialist paediatric hospital: an observational study.
Vestesson E; Booth J; Hatcher J; McGarrity O; Sebire NJ; Steventon A; Suarez Alonso C; Tomlin S; Standing JF
J Antimicrob Chemother; 2022 Mar; 77(4):1185-1188. PubMed ID: 35134183
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
20. Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics.
Tomic T; Henman M; Tadic I; Antic Stankovic J; Santric Milicevic M; Bukumiric Z; Lakic D; Odalovic M
J Infect Dev Ctries; 2024 Apr; 18(4):504-512. PubMed ID: 38728639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
